Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration is seeking revisions to prescribing information for testosterone replacement therapies after concluding that newer clinical evidence no longer supports certain longstanding restrictions …
FDA Seeks Testosterone Label Changes After Evidence Review Read More
EXTON, PA — ProRx Pharma said it expanded its operations, tripled production capacity, and entered new markets to meet growing demand for compounded medications.
Inside ProRx’s Rapid Expansion: Production Triples, Footprint Grows Read More WASHINGTON, D.C. — Federal regulators are exploring whether testosterone replacement therapy could be expanded to treat low libido in certain men, a move that could broaden access to treatment for …
FDA Signals Potential Expansion of Testosterone Therapy Use Read More EXTON, PA — ProRx Pharma says it has begun commercial distribution of a needle-free oral testosterone therapy, positioning the product as a first-of-its-kind alternative designed to deliver the effects of …
No Shots, New Choice: Pa. Firm Launches Needle-Free Oral Testosterone Read More EXTON, PA — ProRx Pharma launched a patented Liquid Nanoemulsion Delivery System that offers a needle-free alternative to injectable medications and, according to the company, positions ProRx as the only …
ProRx Bets on Needle-Free Nanoemulsions—Will Faster Absorption Win? Read More